InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.06
(
0.17%
)
Bitcoin
57,233.30
(
-4.87%
)
Post# of 68830
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

strangelove

Send PM Follow Ignore
Followers 0
Posts 23
Boards Moderated 0
Alias Born 02/23/2014

strangelove

Re: None

Wednesday, 05/21/2014 8:59:23 AM

Wednesday, May 21, 2014 8:59:23 AM

Post# of 68830
Read through this 10-K. It would make sense if the licensee was this company or one like it. The LLC (Eyetalk365) would be the subsidiary formed for the sole purpose of monetizing the patent portfolio. The 60% for them and 40% for REVO mirrors this company's Hybrid Partnering Model. I really hope the licensee is this company since it is one of the biggest in the business and has the horsepower to go after the big boys and win. Target recovery of advanced capital is 18 months. After return of capital infusion, net profit revenue share with partner commences.
http://www.sec.gov/Archives/edgar/data/934549/000093454914000004/actg2013123110-k.htm
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up